Chemoinformaics analysis of (E,Z,Z)-2,4,7-Tridecatrienal
| Molecular Weight | 192.302 | nRot | 8 |
| Heavy Atom Molecular Weight | 172.142 | nRig | 4 |
| Exact Molecular Weight | 192.151 | nRing | 0 |
| Solubility: LogS | -3.232 | nHRing | 0 |
| Solubility: LogP | 3.51 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 34 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 14 | No. of Aromatic Carbocycles | 0 |
| nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 20 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 13 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 1 | No. of Arom Bond | 0 |
| nHA | 1 | APOL | 35.8479 |
| nHD | 0 | BPOL | 20.9321 |
| QED | 0.324 |
| Synth | 3.014 |
| Natural Product Likeliness | 2.114 |
| NR-PPAR-gamma | 0.005 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0.006 |
| Pgp-sub | 0.003 |
| HIA | 0.005 |
| CACO-2 | -4.493 |
| MDCK | 0.0000291 |
| BBB | 0.977 |
| PPB | 0.718629 |
| VDSS | 2.271 |
| FU | 0.113154 |
| CYP1A2-inh | 0.603 |
| CYP1A2-sub | 0.384 |
| CYP2c19-inh | 0.139 |
| CYP2c19-sub | 0.713 |
| CYP2c9-inh | 0.047 |
| CYP2c9-sub | 0.109 |
| CYP2d6-inh | 0.099 |
| CYP2d6-sub | 0.292 |
| CYP3a4-inh | 0.221 |
| CYP3a4-sub | 0.248 |
| CL | 7.48 |
| T12 | 0.634 |
| hERG | 0.299 |
| Ames | 0.934 |
| ROA | 0.902 |
| SkinSen | 0.983 |
| Carcinogencity | 0.554 |
| EI | 0.99 |
| Respiratory | 0.958 |
| NR-Aromatase | 0.02 |
| Antiviral | Yes |
| Prediction | 0.538819 |